A biotech hedge fund births a new immunology company
📍 Aftermath
North Immunology went public via a reverse merger with Aethlon Medical and announced a merger to advance a novel IL‑13 × IL‑18 bispecific antibody for atopic dermatitis, with a merger that could put $180 million behind the eczema treatment. The deal sparked a sharp rally in Aethlon’s shares, though later analysis indicated the financial impact was far smaller than the initial surge suggested, and Halper Sadeh LLC opened an investigation into whether the terms were fair for shareholders.
Epilogue added 26d ago, after coverage quieted.
Sources (8)
-
-
-
-
-
-
-
-
A biotech hedge fund births a new immunology company statnews.com · 51d ago broke it first
Where it stands
- Velocity & Diffusion: Coverage escalated across 6 distinct news outlets with 8 published articles, achieving a live velocity of 5.
- Predictive Outlook: Newsylist algorithmic models forecast this story will fade from trending status over the next 24 hours.
- Source Integrity: Verified strictly against primary headline reporting under zero-hallucination protocols.
"A biotech hedge fund births a new immunology company" developed substantial multi-source reporting across the Business sector, tracked across 6 distinct newsrooms by Newsylist.
Key reporting was led by GlobeNewswire, Stock Titan, Yahoo Finance and ts2.tech. Coverage velocity and cross-outlet momentum were measured using Newsylist open coverage telemetry.
Synthesized from multi-source international reporting and live coverage telemetry under Newsylist open intelligence methodology.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 26d ago.
Answered
What drove coverage for A biotech hedge fund births a new immunology company?
Coverage spiked when 6 independent newsrooms published 8 verified reports during this coverage cycle.
How did Newsylist track this trend?
Newsylist monitored article arrival rates, source diversity, and cross-outlet validation in real time.
How fast it spread
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
How do you expect this trend to evolve over the next 24 hours?
Cast your vote to register reader intelligence on the velocity and trajectory of this coverage.